Correlation between active disease and hypercoagulability state in patients with systemic lupus erythematosus

Clin Chim Acta. 2019 Mar:490:107-112. doi: 10.1016/j.cca.2018.12.008. Epub 2018 Dec 10.
[Article in French]

Abstract

Objective: This study has investigated whether high levels of Reticulocytes-C4d (R-C4d) and Platelets-C4d (P-C4d) reflecting recent activity in SLE patients are correlated with changes in natural anticoagulation components, coagulation activation and endothelial injury markers.

Methods: This study included three groups: 1) healthy women (control, n = 30); 2) women with low activity of the disease (SLEDAI 2 K ≤ 4, n = 30); 3) women with active disease (moderate or high activity) (SLEDAI 2 K > 4, n = 30). Median fluorescence intensity (MFI) of R-C4d and P-C4d were determined by flow cytometry using double labeling with specific monoclonal antibodies. Endothelial injury and hypercoagulability were evaluated by measuring Thrombomodulin and D-dimer levels.

Results: Higher MFI index of R-C4d were related to the recent activity of SLE, and higher expression of P-C4d indicated an elevated risk of thrombotic complications. Increased levels of soluble thrombomodulin and D-dimer were observed in patients with active SLE.

Conclusion: R-C4d is helpful to monitor early disease activity and PC4-d may be an important tool to detect a prothrombotic phenotype in SLE. Elevated levels of D-dimer and thrombomodulin add value to P-C4d data and corroborate a hypercoagulable profile in women with SLE, contributing to an increased prothrombotic risk associated with inflammation.

Keywords: Cell bound complement c4d; Hypercoagulability; Platelets; Retyculocytes; Systemic lupus erythematosus.

MeSH terms

  • Adult
  • Aged
  • Blood Coagulation*
  • Blood Platelets / metabolism*
  • Case-Control Studies
  • Complement C4b
  • Female
  • Humans
  • Lupus Erythematosus, Systemic / blood*
  • Lupus Erythematosus, Systemic / physiopathology*
  • Middle Aged
  • Peptide Fragments / blood*
  • Reticulocytes / metabolism*
  • Young Adult

Substances

  • Peptide Fragments
  • Complement C4b
  • complement C4d